<DOC>
	<DOCNO>NCT02232815</DOCNO>
	<brief_summary>This study examine outcome patient treat planned culotte stenting compare outcomes 2 different stent platform , next generation Synergy II Xience Xpedition DES platform .</brief_summary>
	<brief_title>CELTIC Bifurcation Study</brief_title>
	<detailed_description />
	<criteria>Male female patient &gt; 18 year old Females childbearing potential negative pregnancy test Coronary artery disease require revascularization amenable PCI Medina 1,1,1 bifurcation lesion [ 13 ] &gt; 70 % lesion main vessel side branch visual assessment Main branch side branch â‰¥ 2.5mm diameter visual assessment Both vessel require stenting opinion operator Acute myocardial infarction ongoing STelevation Cardiogenic shock Lesion involve leave main coronary artery Lesion involve bypass graft Plan treat &gt; 1 coronary vessel time inclusion Chronic total occlusion target vessel Left ventricular ejection fraction &lt; 20 % Requirement ongoing haemodialysis Lifeexpectancy limit &lt; 12 month due comorbid condition Known allergy Aspirin Known allergy Clopidorel Prasugrel Ticagrelor Known allergy stent drug elutant Known allergy component either Synergy II Xience Xpedition stent system Ongoing participation another investigational device drug study Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>